Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome

被引：3
|
作者：
Souied, Eric H. [1 ]
Cohen, Salomon-Yves [2 ]
de Pouvourville, Gerard [3 ]
Dupeyron, Gerard [4 ]
Latour, Elisabeth [5 ]
Ponthieux, Anne [5 ]
Weber, Michel [6 ]
机构：
[1] UPEC, Creteil Univ Eye Clin, Interc Hosp Creteil, Creteil, France
[2] Ophthalm Ctr Laser & Med Imagery, Paris, France
[3] ESSEC, Cergy Pontoise, France
[4] Univ Nimes Hosp, Dept Ophthalmol, F-30006 Nimes, France
[5] Novartis Pharma SAS, Rueil Malmaison, France
[6] Hotel Dieu Univ Hosp, Dept Ophthalmol, Nantes, France
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷 / 02期
关键词：
DISEASE;
D O I：
10.1111/aos.12517
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [1] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [2] Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
    Droege, Katharina M.
    Muether, Philipp S.
    Hermann, Manuel M.
    Caramoy, Albert
    Viebahn, Ulrike
    Kirchhof, Bernd
    Fauser, Sascha
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (05) : 1281 - 1284
  • [3] Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
    Katharina M. Droege
    Philipp S. Muether
    Manuel M. Hermann
    Albert Caramoy
    Ulrike Viebahn
    Bernd Kirchhof
    Sascha Fauser
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 1281 - 1284
  • [4] Quality of Life of Patients with Wet Age-Related Macular Degeneration Under Treatment with Ranibizumab
    Charonis, Alexandros
    Datseris, Ioannis
    Androudi, Sophia
    Lake, Symeon
    Tranos, Paris
    Asteriadis, Solon
    Kousidou, Olga
    Pantelopoulou, Georgia
    OPHTHALMOLOGICA, 2014, 232 : 9 - 9
  • [5] Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life
    Cazet-Supervielle, Agathe
    Gozlan, Julien
    Cabasson, Severin
    Boissonnot, Michele
    Manic, Helene
    Leveziel, Nicolas
    OPHTHALMOLOGICA, 2015, 234 (01) : 26 - 32
  • [6] Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
    Dervenis, Nikolaos
    Younis, Saad
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 1117 - 1122
  • [7] Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab
    Chaudhary, Varun
    Brent, Michael
    Lam, Wai-Ching
    Devenyi, Robert
    Teichman, Joshua
    Mak, Michael Ying-Kit
    Kaur, Harneel
    Barbosa, Joshua
    Carter, Ronald
    Farrokhyar, Forough
    OPHTHALMOLOGICA, 2018, 239 (04) : 240 - 240
  • [8] Ranibizumab: Present and Future in the Treatment of the Wet Age-Related Macular Degeneration (Wamd)
    Gimenez Arnau, Jose Maria
    Diaz, Josep Maria
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 37 - 37
  • [9] Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
    Chen, Youxin
    Han, Fei
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 343 - 351
  • [10] Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration
    Desideri, Lorenzo Ferro
    Barra, Fabio
    Ferrero, Simone
    Traverso, Carlo Enrico
    Nicolo, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 735 - 751
12345